Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Leder, K; Weller, PF; Wilson, ME
   Travel vaccines and elderly persons: Review of vaccines available in the United States
   CLINICAL INFECTIOUS DISEASES
   
   K. Leder et al., "Travel vaccines and elderly persons: Review of vaccines available in the United States", CLIN INF D, 33(9), 2001, pp. 1553-1566
2. Kain, KC; Shanks, GD; Keystone, JS
   Malaria chemoprophylaxis in the age of drug resistance. I. Currently recommended drug regimens
   CLINICAL INFECTIOUS DISEASES
   
   K.C. Kain et al., "Malaria chemoprophylaxis in the age of drug resistance. I. Currently recommended drug regimens", CLIN INF D, 33(2), 2001, pp. 226-234
3. Wang, JY; Pasetti, MF; Noriega, FR; Anderson, RJ; Wasserman, SS; Galen, JE; Sztein, MB; Levine, MM
   Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated Delta guaBA Salmonella enterica serovar Typhi strain CVD 915
   INFECTION AND IMMUNITY
   
   J.Y. Wang et al., "Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated Delta guaBA Salmonella enterica serovar Typhi strain CVD 915", INFEC IMMUN, 69(8), 2001, pp. 4734-4741
4. Shata, MT; Stevceva, L; Agwale, S; Lewis, GK; Hone, DM
   Recent advances with recombinant bacterial vaccine vectors
   MOLECULAR MEDICINE TODAY
   
   M.T. Shata et al., "Recent advances with recombinant bacterial vaccine vectors", MOL MED TOD, 6(2), 2000, pp. 66-71
5. Wang, JY; Noriega, FR; Galen, JE; Barry, E; Levine, MM
   Constitutive expression of the vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar typhi oral vaccine strain CVD 909
   INFECTION AND IMMUNITY
   
   J.Y. Wang et al., "Constitutive expression of the vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar typhi oral vaccine strain CVD 909", INFEC IMMUN, 68(8), 2000, pp. 4647-4652
6. Cryz, SJ
   BERNA: a century of immunobiological innovation - Introduction
   VACCINE
   
   S.J. Cryz, "BERNA: a century of immunobiological innovation - Introduction", VACCINE, 17, 1999, pp. S1-S5
7. Levine, MM; Ferreccio, C; Abrego, P; San Martin, O; Ortiz, E; Cryz, S
   Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine
   VACCINE
   
   M.M. Levine et al., "Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine", VACCINE, 17, 1999, pp. S22-S27
8. Peter, G; des-Vignes-Kendrick, M; Eickhoff, TC; Fine, A; Galvin, V; Levine, MM; Maldonado, YA; Marcuse, EK; Monath, TPC; Osborn, JE; Macy, J; Plotkin, S; Poland, GA; Quinlisk, MP; Smith, DR; Sokol, M; Soland, DB; Whitley-Williams, PN; Williamson, DE; Breiman, RF; Arvin, A; Baylor, N; Breiman, R; Clements-Mann, ML; Couch, R; Douglas, G; Galambos, L; Gellin, B; Gershon, A; Glass, R; Gordon, L; Glode, M; Greenberg, H; Hardegree, C; Heilman, C; Hilleman, M; Jordan, W; Levine, MM; Marcuse, E; Paradiso, P; Parkman, P; Plotkin, S; Quinnan, G; Rabinovich, R; Read, L; Russell, P; Sewell, J; Shepherd, HR; Siber, G; Soland, D; Ward, J; White, J; Wright, P
   Lessons learned from a review of the development of selected vaccines
   PEDIATRICS
   
   G. Peter et al., "Lessons learned from a review of the development of selected vaccines", PEDIATRICS, 104(4), 1999, pp. 942-950
9. Tarr, PE; Kuppens, L; Jones, TC; Ivanoff, B; Aparin, PG; Heymann, DL
   Considerations regarding mass vaccination against typhoid fever as an adjunct to sanitation and public health measures: Potential use in an epidemic in Tajikistan
   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
   
   P.E. Tarr et al., "Considerations regarding mass vaccination against typhoid fever as an adjunct to sanitation and public health measures: Potential use in an epidemic in Tajikistan", AM J TROP M, 61(1), 1999, pp. 163-170
10. COOKSON BT; BEVAN MJ
    IDENTIFICATION OF A NATURAL T-CELL EPITOPE PRESENTED BY SALMONELLA-INFECTED MACROPHAGES AND RECOGNIZED BY T-CELLS FROM ORALLY IMMUNIZED MICE
    The Journal of immunology
    
    B.T. Cookson e M.J. Bevan, "IDENTIFICATION OF A NATURAL T-CELL EPITOPE PRESENTED BY SALMONELLA-INFECTED MACROPHAGES AND RECOGNIZED BY T-CELLS FROM ORALLY IMMUNIZED MICE", The Journal of immunology, 158(9), 1997, pp. 4310-4319
11. IVANOFF B; LEVINE MM
    TYPHOID-FEVER - CONTINUING CHALLENGES FROM A RESILIENT BACTERIAL FOE
    Bulletin de l'Institut Pasteur
    
    B. Ivanoff e M.M. Levine, "TYPHOID-FEVER - CONTINUING CHALLENGES FROM A RESILIENT BACTERIAL FOE", Bulletin de l'Institut Pasteur, 95(3), 1997, pp. 129-142
12. CLEMENS J; BRENNER R; RAO M; TAFARI N; LOWE C
    EVALUATING NEW VACCINES FOR DEVELOPING-COUNTRIES - EFFICACY OR EFFECTIVENESS
    JAMA, the journal of the American Medical Association
    
    J. Clemens et al., "EVALUATING NEW VACCINES FOR DEVELOPING-COUNTRIES - EFFICACY OR EFFECTIVENESS", JAMA, the journal of the American Medical Association, 275(5), 1996, pp. 390-397
13. CHONG C; BOST KL; CLEMENTS JD
    DIFFERENTIAL PRODUCTION OF INTERLEUKIN-12 MESSENGER-RNA BY MURINE MACROPHAGES IN RESPONSE TO VIABLE OR KILLED SALMONELLA SPP
    Infection and immunity
    
    C. Chong et al., "DIFFERENTIAL PRODUCTION OF INTERLEUKIN-12 MESSENGER-RNA BY MURINE MACROPHAGES IN RESPONSE TO VIABLE OR KILLED SALMONELLA SPP", Infection and immunity, 64(4), 1996, pp. 1154-1160
14. BENNISH ML
    IMMUNIZATION AGAINST SALMONELLA-TYPHI
    Infectious diseases in clinical practice
    
    M.L. Bennish, "IMMUNIZATION AGAINST SALMONELLA-TYPHI", Infectious diseases in clinical practice, 4(2), 1995, pp. 114-122
15. FERGUSON A; SALLAM J; OMAHONY S; POXTON I
    CLINICAL INVESTIGATION OF GUT IMMUNE-RESPONSES
    Advanced drug delivery reviews
    
    A. Ferguson et al., "CLINICAL INVESTIGATION OF GUT IMMUNE-RESPONSES", Advanced drug delivery reviews, 18(1), 1995, pp. 53-71
16. MIRZA NB; WAMOLA IA; ESTAMBALE BA; MBITHI E; POILLET M
    TYPHIM-VI VACCINE AGAINST TYPHOID-FEVER - A CLINICAL-TRIAL IN KENYA
    East African medical journal
    
    N.B. Mirza et al., "TYPHIM-VI VACCINE AGAINST TYPHOID-FEVER - A CLINICAL-TRIAL IN KENYA", East African medical journal, 72(3), 1995, pp. 162-164
17. PLOTKIN SA; BOUVERETLECAM N
    A NEW TYPHOID VACCINE COMPOSED OF THE VI CAPSULAR POLYSACCHARIDE
    Archives of internal medicine
    
    S.A. Plotkin e N. Bouveretlecam, "A NEW TYPHOID VACCINE COMPOSED OF THE VI CAPSULAR POLYSACCHARIDE", Archives of internal medicine, 155(21), 1995, pp. 2293-2299
18. LEVINE MM; NORIEGA F
    VACCINES TO PREVENT ENTERIC INFECTIONS
    Bailliere's clinical gastroenterology
    
    M.M. Levine e F. Noriega, "VACCINES TO PREVENT ENTERIC INFECTIONS", Bailliere's clinical gastroenterology, 7(2), 1993, pp. 501-517
19. LEVIN JH; CLARKE PD
    TRAVEL VACCINES - A REVIEW OF CURRENT THINKING
    British Medical Bulletin
    
    J.H. Levin e P.D. Clarke, "TRAVEL VACCINES - A REVIEW OF CURRENT THINKING", British Medical Bulletin, 49(2), 1993, pp. 326-347